ATE88899T1 - Wundheilung und knochenregeneration. - Google Patents

Wundheilung und knochenregeneration.

Info

Publication number
ATE88899T1
ATE88899T1 AT87907900T AT87907900T ATE88899T1 AT E88899 T1 ATE88899 T1 AT E88899T1 AT 87907900 T AT87907900 T AT 87907900T AT 87907900 T AT87907900 T AT 87907900T AT E88899 T1 ATE88899 T1 AT E88899T1
Authority
AT
Austria
Prior art keywords
wound healing
bone regeneration
mammal
growth factor
healing
Prior art date
Application number
AT87907900T
Other languages
English (en)
Inventor
Harold C Antoniades
Ray C Williams
Samuel E Lynch
Original Assignee
Inst Molecular Biology Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Molecular Biology Inc, Harvard College filed Critical Inst Molecular Biology Inc
Application granted granted Critical
Publication of ATE88899T1 publication Critical patent/ATE88899T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/49—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87907900T 1986-11-14 1987-11-13 Wundheilung und knochenregeneration. ATE88899T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93076286A 1986-11-14 1986-11-14
PCT/US1987/002975 WO1988003409A1 (en) 1986-11-14 1987-11-13 Wound healing and bone regeneration
EP87907900A EP0289584B1 (de) 1986-11-14 1987-11-13 Wundheilung und knochenregeneration

Publications (1)

Publication Number Publication Date
ATE88899T1 true ATE88899T1 (de) 1993-05-15

Family

ID=25459724

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907900T ATE88899T1 (de) 1986-11-14 1987-11-13 Wundheilung und knochenregeneration.

Country Status (15)

Country Link
EP (1) EP0289584B1 (de)
JP (1) JPH01500199A (de)
KR (1) KR960005708B1 (de)
CN (1) CN1027346C (de)
AT (1) ATE88899T1 (de)
AU (1) AU600069B2 (de)
DE (1) DE3785758T2 (de)
DK (1) DK175889B1 (de)
IE (1) IE60517B1 (de)
MX (1) MX170454B (de)
NO (1) NO883127L (de)
NZ (1) NZ222551A (de)
OA (1) OA09159A (de)
WO (1) WO1988003409A1 (de)
ZA (1) ZA878566B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4889919A (en) * 1986-08-13 1989-12-26 Zymogenetics, Inc. Biologically active PDGF derived A-chain homodimers
US5474982A (en) * 1986-08-13 1995-12-12 Zymogenetics, Inc. PDGF analogs and methods of use
US4885163A (en) * 1987-02-24 1989-12-05 Eli Lilly And Company Topical use of IGF-II for wound healing
IL95641A0 (en) * 1989-09-15 1991-06-30 Curative Tech Inc Preparation of a platelet releasate product
ZA9010332B (en) * 1989-12-22 1991-08-28 Ciba Geigy Method of reducing or preventing adverse effect of steroid therapy and compositions therefor
EP0479799B1 (de) * 1990-04-10 1997-08-06 Institute Of Molecular Biology Inc. Wundheilung
EP0531425B1 (de) * 1990-05-30 2002-08-14 The President And Fellows Of Harvard College Kombination aus IGF-I und TGF-beta zur Knochenregenerierung
US6117425A (en) 1990-11-27 2000-09-12 The American National Red Cross Supplemented and unsupplemented tissue sealants, method of their production and use
US6197325B1 (en) 1990-11-27 2001-03-06 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
US7208179B1 (en) 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
AU3062392A (en) * 1991-11-04 1993-06-07 Novo Nordisk A/S Pdgf gel formulation
FR2691911B1 (fr) * 1992-06-05 1994-11-25 Delmas Olivier Dispositif permettant l'obtention d'un surnageant de thrombocytes activés, procédé mettant en Óoeuvre le dispositif et surnageant obtenu.
CA2114419A1 (en) * 1992-06-08 1993-12-23 Peter D. Gluckman Use of growth factor igf-i and/or igf-ii
FR2696095B1 (fr) * 1992-09-30 1994-11-25 Inoteb Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application.
CN1055023C (zh) * 1993-01-03 2000-08-02 周至譓 伤口护理剂
JP3699111B2 (ja) * 1993-03-29 2005-09-28 ザイモジェネティクス，インコーポレイティド Ｐｄｇｆおよびビタミンｄを含有する骨芽細胞の成長を刺激する組成物
US7026299B2 (en) 1994-07-12 2006-04-11 Human Genome Sciences, Inc. Connective tissue growth factor-2
EP0804562B1 (de) 1994-07-12 2002-10-09 Human Genome Sciences, Inc. Bindegewebswachstumsfaktor-2
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
ATE274056T1 (de) * 1995-10-11 2004-09-15 Chiron Corp Kombination pdgf, kgf, igf und igfbp zur wundheilung
WO1998025963A1 (en) 1996-12-13 1998-06-18 Chiron Corporation Analysis and separation of platelet-derived growth factor proteins
US6663870B2 (en) 1998-12-07 2003-12-16 Zymogenetics, Inc. Methods for promoting growth of bone using zvegf3
US6468543B1 (en) 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
GB2369572A (en) 2000-11-29 2002-06-05 Raft Trustees Ltd Wound treatment composition comprising insulin
US7241874B2 (en) 2002-06-26 2007-07-10 Zimmer Ortho Biologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7622562B2 (en) 2002-06-26 2009-11-24 Zimmer Orthobiologics, Inc. Rapid isolation of osteoinductive protein mixtures from mammalian bone tissue
US7473678B2 (en) 2004-10-14 2009-01-06 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods of use thereof
KR20080084808A (ko) 2005-11-17 2008-09-19 바이오미메틱 세라퓨틱스, 인크. ｒｈＰＤＧＦ-ＢＢ 및 생체적합성 매트릭스를 사용하는상악안면골 보강
ES2427993T3 (es) 2006-02-09 2013-11-05 Biomimetic Therapeutics, Llc Composiciones y métodos para el tratamiento de hueso
US9161967B2 (en) 2006-06-30 2015-10-20 Biomimetic Therapeutics, Llc Compositions and methods for treating the vertebral column
US9642891B2 (en) 2006-06-30 2017-05-09 Biomimetic Therapeutics, Llc Compositions and methods for treating rotator cuff injuries
WO2008073628A2 (en) 2006-11-03 2008-06-19 Biomimetic Therapeutics, Inc. Compositions and methods for arthrodetic procedures
AU2009212151C1 (en) 2008-02-07 2015-09-17 Stryker Corporation Compositions and methods for distraction osteogenesis
MX2011002555A (es) 2008-09-09 2011-08-03 Biomimetic Therapeutics Inc Composiciones de factor de crecimiento derivadas de plaquetas y metodo para el tratamiento de lesiones de tendon y ligamentos.
WO2011103598A1 (en) 2010-02-22 2011-08-25 Biomimetic Therapeutics, Inc. Platelet-derived growth factor compositions and methods for the treatment of tendinopathies
CN102397534B (zh) * 2010-09-07 2013-10-23 中国人民解放军总医院 胰岛素在制备促进颌骨组织愈合的药物中的用途
KR101965592B1 (ko) * 2011-11-22 2019-08-13 (주)아모레퍼시픽 성장 인자를 포함하는 피부 재생 촉진제
CA2962954A1 (en) 2014-10-14 2016-04-21 Samuel Lynch Compositions for treating wounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4479896A (en) * 1981-12-11 1984-10-30 Antoniades Harry N Method for extraction localization and direct recovery of platelet derived growth factor

Also Published As

Publication number Publication date
AU8328987A (en) 1988-06-01
IE873075L (en) 1988-05-14
KR960005708B1 (ko) 1996-05-01
JPH01500199A (ja) 1989-01-26
OA09159A (en) 1992-03-31
WO1988003409A1 (en) 1988-05-19
DE3785758T2 (de) 1993-08-05
EP0289584A4 (de) 1990-01-08
NZ222551A (en) 1989-11-28
IE60517B1 (en) 1994-07-27
NO883127D0 (no) 1988-07-13
DK393288D0 (da) 1988-07-14
EP0289584B1 (de) 1993-05-05
NO883127L (no) 1988-09-12
MX170454B (es) 1993-08-24
DK175889B1 (da) 2005-05-30
DK393288A (da) 1988-09-13
JPH0581569B2 (de) 1993-11-15
AU600069B2 (en) 1990-08-02
DE3785758D1 (de) 1993-06-09
CN1027346C (zh) 1995-01-11
EP0289584A1 (de) 1988-11-09
ZA878566B (en) 1989-07-26
KR890700033A (ko) 1989-03-02
CN87101250A (zh) 1988-06-08

Similar Documents

Publication Publication Date Title
ATE88899T1 (de) Wundheilung und knochenregeneration.
ATE109352T1 (de) Heilung von wunden.
DE69031218D1 (de) Wundheilung
CA2040410A1 (en) Wound healing compositions containing il-1 and a growth factor
ATE196604T1 (de) Zusammensetzung enthaltend pdgf und dexamethason zur förderung von gewebsreparatur und - regenerierung
FI935306A7 (fi) Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana
GB8707605D0 (en) Occulsive wound care dressing
KR900700128A (ko) 외상 치료법
NO165375C (no) Instrument for behandling av luftveishindringer.
EP0190018A3 (en) Use of transforming growth factor to promote wound healing and composition therefor
GR3002672T3 (en) Compositions and methods for the treatment of bleeding disorders
KR890007782A (ko) 산성 기체 흡수제 조성물
IT8620902A0 (it) Composizioni contenenti acido usnico o suoi derivati atte all'impiego nel trattamento della carie dentaria.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE70715T1 (de) Bindungsinduzierende komposition.
ATE181082T1 (de) Fibroblastwachstumsfaktor und ascorbinsäure enthaltende wundheilungszusammensetzungen
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
ATE222117T1 (de) Kombination aus igf-i und tgf-beta zur knochenregenerierung
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
ATE51520T1 (de) Kosmetikum.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE3372068D1 (en) Pharmaceutical compositions for treating resistant bacteria including anaerobes
DE59008759D1 (de) Verwendung von interleukin-2 zur behandlung der endotoxinämie.
ATE97574T1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside fuer heilung von wunden.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time